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Conclusion
Origin of LSCA from the AA can be explained by Edwards’ double
arch hypothesis.3 The right arch has fully developed. In addition, there
is persistence of a part of the left fourth aortic arch and seventh left
ISA in tandem forming the LSCA.
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Intermediate outcomes of fenestrated Fontan procedures
S. Garekar, MD,a H. L. Walters, III, MD,b R. E. Delius, MD,b R. L. Thomas, PhD,c and R. D. Ross, MD,a Detroit, Mich
T he fenestrated Fontan (FF) procedure is associated withbetter hemodynamics postoperatively than the modifiedFontan procedure without a fenestration.1,2 Although afenestration improves cardiac output, there is a cost of
right-to-left shunting, cyanosis, and the subsequent risk of throm-
boembolism.
Our goal was to evaluate our experience with FF procedures.
Specifically, we sought (1) to assess the outcomes of closed
fenestrations, (2) to determine the rate of spontaneously closed
fenestrations, and (3), among patients with patent fenestrations, to
determine whether a clinical or laboratory variable could be used
to predict their outcomes.
After institutional review board approval, 23 FF procedures
with no other source of significant right-to-left shunt were identi-
fied. The cardiac lesion in the majority of patients (16/23 [70%])
was hypoplastic left heart syndrome.
Pre-Fontan Catheterization Hemodynamics
The average mean pulmonary artery pressure was 11  2.8 mm
Hg. The mean pulmonary vascular resistance (PVR) was 2.3 1.5
indexed Wood units. The mean systemic ventricular end-diastolic
pressure was 7.8  2.6 mm Hg.
Surgical Results
The mean age at the time of the operation was 24.7  9 months.
Twenty-two of the 23 patients received the lateral tunnel Fontan
procedure, and the remaining patient received an extracardiac
conduit. The fenestration was a single 4-mm punch in 14 patients.
Additional procedures performed along with the Fontan procedure
were pulmonary artery patch angioplasty (n  4) and atrioventric-
ular (AV) valvuloplasty (n  3). The mean hospital stay after
surgical intervention was 13.4  7.4 days. The median follow-up
period after the Fontan procedure was 16 months (range, 2-134
months).
Spontaneously Closed Fenestrations
There was spontaneous closure of the fenestration in 5 (22%)
patients (Table 1). One of these did not tolerate this closure and has
had a transplantation. The other 4 patients are clinically stable. The
size of the fenestrations varied from 2 punches of 2.5 mm (n  2),
a single 4-mm punch (n  2), and a single 5-mm punch (n  1).
There was no correlation between the size of fenestration created
and the likelihood of closure.
Catheterization Laboratory Closure of Fenestrations
Data on catheterization laboratory closure of fenestrations are
shown in Table 1. Three patients were referred to the catheter-
ization laboratory for device closure of the fenestration, of
which 2 underwent device placement after favorable hemody-
namics were demonstrated on test occlusion of the fenestration.
The patients were referred for device closure because of de-
saturation in 2 patients and persistent headaches in the third.
There were no infarcts seen on brain imaging in the patient
with headaches, and the headaches have persisted after device
closure.
Patent Fenestrations
There were 20 patients with complete data, of whom 14 had patent
fenestrations. The cohort was divided into 3 groups on the basis of
fenestration status on the most recent echocardiogram: group 1,
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closed fenestration; group 2, patent fenestration and low resting
saturation (94%); and group 3, patent fenestration but normal
resting saturation (94%).
Comparison Between Groups
Data on comparison between groups are shown in Table 2. There
was no difference between the groups with respect to age at the
time of the Fontan procedure, the pre-Fontan mean pulmonary
artery pressure, or the systemic ventricular end-diastolic pressure.
The preoperative PVR was significantly lower in group 3 (P 
.05). No group 3 patients had significant AV valve regurgitation or
ventricular dysfunction at the most recent clinic visit. Patients in
groups 1 and 2 had a higher incidence of moderate or severe
decrease of ventricular function, New York Heart Association
class 2 or greater, and hepatomegaly at the most recent clinic visit
when compared with group 3.
Discussion
Historically, the interval between the FF procedure and device
closure of the fenestration has ranged from less than a week to 3
years postoperatively.3,4 The trend has been to wait at least 6
months before contemplating closure. Waiting for a longer period
exposes the patient to potential adverse effects of cyanosis and the
risk of thromboembolism. No patient in this study had clinically
detectable thromboembolism. Our data show that spontaneous
TABLE 1. Patients with spontaneous or device closure of fenestrations
Patient
no. Lesion Pre-Fontan MAP/PVR
Time to closure from
surgical date Clinical course after closure
Spontaneous closure of fenestrations (n  5)
8 HLHS 13 mm Hg/4.8 WU 12 mo Experienced protein-losing enteropathy. A fenestration was
recreated in the catheterization laboratory. Worsened
clinically. Listed and received a heart transplant.
10 Pulmonary atresia/IVS 14 mm Hg/3.3 WU 9 mo NYHA class I
16 HLHS 16 mm Hg/5.4 WU 83 mo NYHA class I
19 HLHS 9 mm Hg/3 WU 11 mo NYHA class I
23 Complex single ventricle 9 mm Hg/3.4 WU 2 mo NYHA class I
Device closure of fenestrations (n  2)
18 HLHS 10 mm Hg/5.6 WU 15 mo Experienced frank congestive heart failure within 2 wk of
closure. Managed with diuretics; currently stable NYHA
class II.
21 DORV with mitral atresia 9 mm Hg/1.4 WU 11 mo Currently stable NYHA class I
MAP, Mean pulmonary artery pressure; PVR, pulmonary vascular resistance; HLHS, hypoplastic left heart syndrome; WU, indexed Woods units; IVS, intact
ventricular septum; NYHA, New York Heart Association; DORV, double-outlet right ventricle.












Age (mo) at FF (mean  SD) 25.6 8.3 20.4 2.5 33.7  17.7
Pre-FF: pulmonary pressure (mm Hg) 11.4 2.9 11.2 2.7 9  3.5
Pre-FF: pulmonary vascular resistance (indexed Woods units) 3.8 1.6 1.7 0.8 1.0  0.2
Type of fenestration
Single punch
4 mm n  3 n  7 n  3
5 mm n  2 n  1 n  0
Two punches 2.5 mm  2: n  2 3.5 mm  2: n  1 3.5 mm  2: n  1
Pre-FF: end-diastolic pressure (mm Hg) 7.1 2.5 8.2  2.2 8 4.4
Post-FF hospital stay 17.7 9.2 10.3  4 10.2  6.6
Moderate AV valve regurgitation at recent visit, n 1 (14%) 4 (44%) 0 (0%)
Mild decreased ventricular function at recent visit, n 2 (29%) 4 (44%) 0 (0%)
NYHA class 2 at recent visit, n 3 (43%) 3 (33%) 0 (0%)
Hepatomegaly at recent visit, n 5 (71%) 5 (56%) 1 (25%)
Transplantation, n 1 (14%) 1 (11%) 0 (0%)
FF, Fenestrated Fontan procedure; SD, standard deviation; AV, atrioventricular; NYHA, New York Heart Association.
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closure can occur as early as 2 months and up to 83 months after
the operation. Closure of fenestration was not necessarily associ-
ated with a good outcome.
There are some proponents of the view that fenestrations
should not be closed because they preserve cardiac output and
prevent central venous pressure from increasing. This seems
like a good option for the patients in our study with patent
fenestrations whose resting peripheral arterial saturations were
normal. The patients in this group had no significant AV leak-
age or ventricular dysfunction and were doing well clinically at
the most recent clinic visit. These patients might have done well
in part because of a lower pre-Fontan PVR. Whether patients
with patent fenestrations but low resting saturations would
benefit from device closure requires further study; however,
those within this group who have preserved ventricular function
and minimal AV regurgitation might be good candidates for this
procedure.
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